307
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Evaluation of intraoperative glove change in prevention of postoperative cerebrospinal fluid shunt infections, and the predictors of shunt infection

&
Pages 452-458 | Received 02 Aug 2015, Accepted 23 Aug 2016, Published online: 14 Sep 2016

References

  • Choux M, Genitori L, Lang D, Lena G. Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 1992;77:875–80.
  • Eymann R, Chehab S, Stromitzki M, et al. Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters. J Neurosurg Pediatr 2008;1:444–50.
  • McGirt MJ, Woodworth G, Coon AL, et al. Diagnosis, treatment, and analysis of long-term outcomes in idiopathic normal-pressure hydrocephalus. Neurosurgery 2005;57:699–705.
  • McGirt MJ, Woodworth G, Thomas G, et al. Cerebrospinal fluid shunt placement for pseudo-tumor cerebri-associated intractable headache: predictors of treatment response and an analysis of long-term outcomes. J Neurosurg 2004;101:627–32.
  • Puca A, Anile C, Maira G, Rossi G. Cerebrospinal fluid shunting for hydrocephalus in the adult: factors related to shunt revision. Neurosurgery 1991;29:822–6.
  • Spanu G, Karussos G, Adinolfi D, Bonfanti N. An analysis of cerebrospinal fluid shunt infections in adults. A clinical experience of twelve years. Acta Neurochir (Wien) 1986;80:79–82.
  • Pople IK, Bayston R, Hayward RD. Infection of cerebrospinal fluid shunts in infants: a study of etiological factors. J Neurosurg 1992;77:29–36.
  • Fan-Havard P, Nahata MC. Treatment and prevention of infections of cerebrospinal fluid shunts. Clin Pharm 1987;6:866–80.
  • Ronan A, Hogg GG, Klug GL. Cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J 1995;14:782–6.
  • Wells DL, Allen JM. Ventriculoperitoneal shunt infections in adult patients. AACN Advanced Critical Care 2013;24:6–12.
  • McGirt MJ, Zaas A, Fuchs HE, et al. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis 2003;36:858–62.
  • Vinchon M, Dhellemmes P. Cerebrospinal fluid shunt infection: risk factors and long-term follow-up. Childs Nerv Syst 2006;22:692–7.
  • Borgbjerg BM, Gjerris F, Albeck MJ, Børgesen SE. Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien) 1995;136:1–7.
  • Kestle JR, Garton HJ, Whitehead WE, et al. Management of shunt infections: a multicenter pilot study. J Neurosurg 2006;105:177–81.
  • Sørensen P, Ejlertsen T, Aaen D, Poulsen K. Bacterial contamination of surgeons gloves during shunt insertion: a pilot study. Br J Neurosurgery 2008;22:675–7.
  • Lee JK, Seok JY, Lee JH, et al. Incidence and risk factors of ventriculoperitoneal shunt infections in children: a study of 333 consecutive shunts in 6 years. J Korean Med Sci 2012;27:1563–8.
  • Odio C, McCracken GH, Jr, Nelson JD. CSF shunt infections in pediatrics. A seven-year experience. Am J Dis Child 1984;138:1103–8.
  • Kontny U, Hofling B, Gutjahr P, et al. CSF shunt infections in children. Infection 1993;21:89–92.
  • Cochrane D, Kestle J, Steinbok P, et al. Model for the cost analysis of shunted hydrocephalic children. Pediatr Neurosurg 1995;23:14–19.
  • Rehman A, Rehman T, Bashir HH, Gupta V. A simple method to reduce infection of ventriculoperitoneal shunts. J Neurosurg Pediatric 2010;5:569–72.
  • Wooster DL, Louch RE, Krajden S. Intraoperative bacterial contamination of vascular grafts: a prospective study. Can J Surg 1985;28:407–9.
  • Zdanowski Z, Danielsson G, Jonung T, et al. Intraoperative contamination of synthetic vascular grafts. Effect of glove change before graft implantation. A prospective randomized study. Eur J Vasc Endovasc Surg 2000;19:283–7.
  • Kestle JR, Riva-Cambrin J, Wellons JC, et al. A standardized protocol to reduce cerebrospinal fluid shunt infection: the hydrocephalus clinical research network quality improvement initiative. J Neurosurg Pediatr 2011;8:22–9.
  • Hommelstad J, Madsø A, Eide PK. Significant reduction of shunt infection rate in children below 1 year of age after implementation of a perioperative protocol. Acta Neurochir (Wien) 2013;155:523–31.
  • Pirotte BJM, Lubansu A, Bruneau M, et al. Sterile surgical technique for shunt placement reduces the shunt infection rate in children: preliminary analysis of a prospective protocol in 115 consecutive procedures. Childs Nerv Syst 2007;23:1251–61.
  • Winston KR, Ho JTR, Dolan SA. Recurrent cerebrospinal fluid shunt infection and the efficacy of reusing infected ventricular entry sites. J Neurosurg Pediatr 2013;11:635–42.
  • Gutierrez-Murgas Y, Snowden JN. Ventricular shunt infections: Immunopathogenesis and clinical management. J Neuroimmunol 2014;276:1–8.
  • Bayston R, Ashraf W, Barker-Davies R, et al. Biofilm formation by propionibacterium acnes on biomaterials in vitro and in vivo: impact on diagnosis and treatment. J Biomed Mater Res A 2007;81:705–9.
  • Vanaclocha V, Sáiz-Sapena N, Leiva J. Shunt malfunction in relation to shunt infection. Acta Neurochir (Wien) 1996;138:829–34.
  • Baird C, O’Connor D, Pittman T. Late shunt infections. Pediatr Neurosurg 1999;31:269–73.
  • Korinek A-M, Fulla-Oller L, Boch A-L, et al. Morbidity of ventricular cerebrospinal fluid shunt surgery in adults: an 8-year study. Neurosurgery 2011;68:985–95.
  • Kulkarni AV, Drake JM, Lamberti-Pasculli M. Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg 2011;94:195–201.
  • Bayston R, Ashraf W, Bhundia C. Mode of action of an antimicrobial biomaterial for use in hydrocephalus shunts. J Antimicrob Chemother2004;53:778–82.
  • Kan P, Kestle J. Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infections in children. Childs Nerv Syst 2007;23:773–7.
  • Ritz R, Roser F, Morgalla M, et al. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients. BMC Infect Dis 2007;7:38.
  • Steinbok P, Milner R, Agrawal D, et al. A multicenter multinational registry for assessing ventriculoperitoneal shunt infections for hydrocephalus. Neurosurgery 2010;67:1303–10.
  • Demetriades AK, Bassi S. Antibiotic resistant infections with antibiotic-impregnated Bactiseal catheters for ventriculoperitoneal shunts. Br J Neurosurgery 2011;25:671–3.
  • Jenkinson MD, Gamble C, Hartley JC, et al. The British antibiotic and silver-impregnated catheter for ventriculoperitoneal shunts multi-centre randomised controlled trial (the BASICS trial): study protocol. Trials 2014;15:4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.